menu
    • menu

    Company profile for Bonum Therapeutics

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines. At Good Therapeutics we are developing protein-based drugs with regulated, context-dependent activity. Our new drugs can “sense” their local environment and respond by changing from an inactive form to an active one. Unlike protease-activated therapeutics, the mechanism is re...
    Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines. At Good Therapeutics we are developing protein-based drugs with regulated, context-dependent activity. Our new drugs can “sense” their local environment and respond by changing from an inactive form to an active one. Unlike protease-activated therapeutics, the mechanism is reversible. The active form of the drug can change back to the inactive form when it is no longer in the presence of the activating signal.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bonum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1616 Eastlake Ave E, Seattle, Washington 98102
    Telephone
    Telephone
    206.888.8485
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bonumtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/bonum-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    USPTO Awards Bonum Therapeutics Patent for Active Biologics Tech
    USPTO Awards Bonum Therapeutics Patent for Active Biologics Tech

    13 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250813833113/en/USPTO-Grants-Key-Mechanism-of-Action-Patent-to-Bonum-Therapeutics-for-its-Conditionally-Active-Biologics-Technology

    BUSINESSWIRE
    13 Aug 2025
    Share Share
    Bonum Therapeutics to Join BIO 2025 Panel on Active Biologics
    Bonum Therapeutics to Join BIO 2025 Panel on Active Biologics

    10 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250610342206/en/Bonum-Therapeutics-to-Participate-in-Panel-on-Conditionally-Active-Biologics-at-BIO-2025

    BUSINESSWIRE
    10 Jun 2025
    Share Share
    Bonum Names Samuel Blackman to Board of Directors
    Bonum Names Samuel Blackman to Board of Directors

    03 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241203219932/en

    BUSINESSWIRE
    03 Dec 2024
    Share Share
    Bonum to Present Conditionally Activated Therapy Platform
    Bonum to Present Conditionally Activated Therapy Platform

    29 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240429480337/en

    BUSINESSWIRE
    29 Apr 2024
    Share Share
    Bonum Therapeutics to Present Poster on Lead Program at AACR 2024
    Bonum Therapeutics to Present Poster on Lead Program at AACR 2024

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305949570/en

    BUSINESSWIRE
    05 Mar 2024
    Share Share
    Bonum Therapeutics Announces a $93M Series A Financing
    Bonum Therapeutics Announces a $93M Series A Financing

    15 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221115005420/en

    BUSINESSWIRE
    15 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search